3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Lung Diseases
1
Kidney Neoplasms
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cisplatin
4
Cetuximab
4
cemiplimab
3
Radiotherapy
3
Platinum
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
trastuzumab deruxtecan
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cabozantinib
1
atezolizumab
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Tramadol
1
Taxes
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
zimberelimab
×
30 days
×
Clear all
No trials found.